ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631691 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631691; 2) Community: the network communities that were significantly associated with the response to NSC 631691; 3) Molecule: the relationships between components within communities and NSC 631691; 4) MDR: the compounds that were significantly associated with the NSC 631691.

NSC Compound Enrichment Correlation
NSC 668260 2-(5-Bromouracil-1-yl)-4-methylene-5-oxo-2-(p-phenylphenyl)-2,3,4,5-tetrhydrofuran 0.0115521552688258 -0.13217621
NSC 707691 Null 0.0115521552688258 0.2654746
NSC 720174 Null 0.0115521552688258 0.47001369
NSC 720248 Null 0.0115521552688258 -0.02710956
NSC 735540 5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide 0.0115521552688258 -0.19108156
NSC 10848 Null 0.0123744972338278 0.52638178
NSC 129943 (+-)-(3,5,3',5'-Tetraoxo)-1,2-dipiperazinopropane 0.0123744972338278 -0.0030460772
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.0123744972338278 -0.11872958
NSC 606498 Camptothecin Derivative 0.0123744972338278 0.23907404
NSC 609699 Topotecan hydrochloride 0.0123744972338278 0.010722006
Total:53  Current:12    [First] [Prev] [Next] [Last]